SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1676)5/12/2006 11:16:31 AM
From: Icebrg  Read Replies (1) | Respond to of 1826
 
Agreed, just quoting what was reported. MOGN should however be an interesting target for anyone wanting to establish themselves on the US market.

Erik



To: tuck who wrote (1676)5/12/2006 11:17:33 AM
From: Ward Knutson  Respond to of 1826
 
Chances of MGI accepting their stock = 0 %.

Chances of Wockhardt coming up with $2 billion plus in cash = 0 %.

No deal, no way, not with this Company.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News